Signature Estate & Investment Advisors LLC grew its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 4.7% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 773,627 shares of the financial services provider's stock after purchasing an additional 34,548 shares during the quarter. MetLife makes up approximately 1.5% of Signature Estate & Investment Advisors LLC's holdings, making the stock its 18th biggest position. Signature Estate & Investment Advisors LLC owned about 0.11% of MetLife worth $63,809,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the business. MeadowBrook Investment Advisors LLC lifted its position in shares of MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider's stock valued at $26,000 after buying an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. boosted its position in shares of MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock worth $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC increased its stake in shares of MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock worth $29,000 after purchasing an additional 277 shares in the last quarter. Fortitude Family Office LLC lifted its stake in shares of MetLife by 177.3% during the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider's stock valued at $34,000 after buying an additional 266 shares in the last quarter. Finally, Bank & Trust Co bought a new position in MetLife in the 2nd quarter worth $39,000. Institutional investors own 89.81% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on the company. Wells Fargo & Company boosted their price target on MetLife from $92.00 to $93.00 and gave the stock an "overweight" rating in a report on Tuesday, November 5th. Barclays cut their target price on shares of MetLife from $91.00 to $90.00 and set an "overweight" rating for the company in a research note on Thursday, October 31st. Morgan Stanley decreased their price target on shares of MetLife from $86.00 to $85.00 and set an "overweight" rating on the stock in a research note on Monday, August 19th. Piper Sandler increased their price objective on shares of MetLife from $85.00 to $92.00 and gave the company an "overweight" rating in a report on Wednesday, October 2nd. Finally, Bank of America reduced their target price on MetLife from $99.00 to $96.00 and set a "buy" rating on the stock in a report on Thursday, August 1st. Fourteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average price target of $88.46.
Read Our Latest Stock Report on MetLife
MetLife Trading Up 0.9 %
MET traded up $0.73 during trading on Friday, reaching $83.33. The company had a trading volume of 4,393,104 shares, compared to its average volume of 3,330,660. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. MetLife, Inc. has a 52 week low of $61.61 and a 52 week high of $86.94. The stock has a market cap of $57.70 billion, a P/E ratio of 16.75, a PEG ratio of 0.74 and a beta of 1.05. The business has a 50 day simple moving average of $81.42 and a 200-day simple moving average of $75.48.
MetLife Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be given a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a yield of 2.62%. The ex-dividend date of this dividend is Tuesday, November 5th. MetLife's dividend payout ratio (DPR) is currently 43.95%.
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
